Brii Biosciences Limited (BRIBF)
OTCMKTS · Delayed Price · Currency is USD
0.1867
0.00 (0.00%)
At close: Dec 24, 2025
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of $130.6 million as of December 31, 2025. Its market cap has increased by 49.39% in one year.
Market Cap
130.60M
Enterprise Value
-167.72M
Revenue
4.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 2.09B to 130.60M, a decrease of -93.74%. That is a compound annual growth rate of -46.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 130.60M | 41.55% |
| Dec 31, 2024 | 92.26M | -56.66% |
| Dec 29, 2023 | 212.88M | -69.02% |
| Dec 30, 2022 | 687.16M | -77.39% |
| Dec 31, 2021 | 3.04B | 45.61% |
| Jul 13, 2021 | 2.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 298.05M |
| Nika Pharmaceuticals | 291.10M |